Echolucent or predominantly echolucent femoral plaques predict early restenosis after eversion carotid endarterectomy

Journal of Vascular Surgery

Volumn 51, Issue 2, 2010, Pages 345-350

  Dósa, Edit ^a,b   Hirschberg, Kristóf ^a   Apor, Astrid ^a   Járányi, Zsuzsanna ^a   Entz, László ^a   Acsády, György ^a   Hüttl, Kálmán ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; COLOR ULTRASOUND FLOWMETRY; FEMALE; FEMORAL ARTERY; HUMAN; HYPERLIPIDEMIA; IMAGING SYSTEM; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RESTENOSIS; THROMBOSIS; TREATMENT OUTCOME; ULTRASOUND; ULTRASOUND TRANSDUCER;

AGED; ATHEROSCLEROSIS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 75149191879     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.08.080     Document Type: Article

References (30)

1. Reina-Gutiérrez T., Serrano-Hernando F.J., Sánchez-Hervás L., Ponce A., Vega de Ceniga M., and Martín A. Recurrent carotid artery stenosis following endarterectomy: natural history and risk factors. Eur J Vasc Endovasc Surg 29 (2005) 334-341
2. Stoney R.J., and String S.T. Recurrent carotid stenosis. Surgery 80 (1976) 705-710
3. Schillinger M., and Minar E. Restenosis after percutaneous angioplasty: the role of vascular inflammation. Vasc Health Risk Manag 1 (2005) 73-78
4. Insull Jr. W. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med 122 (2009) S3-S14
5. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108 (2003) 1664-1672
6. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 108 (2003) 1772-1778
7. Nordestgaard B.G., Grønholdt M.L., and Sillesen H. Echolucent rupture-prone plaques. Curr Opin Lipidol 14 (2003) 505-512
8. Schmidt C., Fagerberg B., and Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis 181 (2005) 125-130
9. Novo G., Maniglia D., Corrado E., Muratori I., Sutera F., Evola S., et al. Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention. Coron Artery Dis 18 (2007) 627-631
10. Sirico G., Brevetti G., Lanero S., Laurenzano E., Luciano R., and Chiariello M. Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. J Vasc Surg 49 (2009) 346-351
11. Brott T., Adams Jr. H.P., Olinger C.P., Marler J.R., Barsan W.G., Biller J., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989) 864-870
12. Redberg R.F., Vogel R.A., Criqui M.H., Herrington D.M., Lima J.A., and Roman M.J. 34th Bethesda Conference: Task force #3-What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis?. J Am Coll Cardiol 41 (2003) 1886-1898
13. Wendelhag I., Wiklund O., and Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13 (1993) 1404-1411
14. Geroulakos G., Ramaswami G., Nicolaides A., James K., Labropoulos N., Belcaro G., et al. Characterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg 80 (1993) 1274-1277
15. Joakimsen O., Bønaa K.H., and Stensland-Bugge E. Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromsø Study. Stroke 28 (1997) 2201-2207
16. Sztajzel R. Ultrasonographic assessment of the morphological characteristics of the carotid plaque. Swiss Med Wkly 135 (2005) 635-3
17. Biller J., Feinberg W.M., Castaldo J.E., Whittemore A.D., Harbaugh R.E., Dempsey R.J., et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 29 (1998) 554-562
18. Grant E.G., Benson C.B., Moneta G.L., Alexandrov A.V., Baker J.D., Bluth E.I., et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 229 (2003) 340-346
19. Mayor I., Momjian S., Lalive P., and Sztajzel R. Carotid plaque: comparison between visual and grey-scale median analysis. Ultrasound Med Biol 29 (2003) 961-966
20. Slevin M., Wang Q., Font M.A., Luque A., Juan-Babot O., Gaffney J., et al. Atherothrombosis and plaque heterology: different location or a unique disease?. Pathobiology 75 (2008) 209-225
21. Stalenhoef A.F. The benefit of statins in non-cardiac vascular surgery patients. J Vasc Surg 49 (2009) 260-265
22. Liapis C.D., Kakisis J.D., Dimitroulis D.A., and Kostakis A.G. The impact of the carotid plaque type on restenosis and future cardiovascular events: a 12-year prospective study. Eur J Vasc Endovasc Surg 24 (2002) 239-244
23. Kitta Y., Obata J.E., Takano H., Nakamura T., Kodama Y., Fujioka D., et al. Echolucent carotid plaques predict in-stent restenosis after bare metal stenting in native coronary arteries. Atherosclerosis 197 (2008) 177-182
24. Grønholdt M.L., Sillesen H., Wiebe B.M., Laursen H., and Nordestgaard B.G. Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume. Eur J Vasc Endovasc Surg 21 (2001) 227-234
25. Andersson J., Sundström J., Kurland L., Gustavsson T., Hulthe J., Elmgren A., et al. The carotid artery plaque size and echogenicity are related to different cardiovascular risk factors in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Lipids 44 (2009) 397-403
26. Liapis C.D., and Paraskevas K.I. Factors affecting recurrent carotid stenosis. Vasc Endovascular Surg 39 (2005) 83-95
27. LaMuraglia G.M., Stoner M.C., Brewster D.C., Watkins M.T., Juhola K.L., Kwolek C., et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg 41 (2005) 762-768
28. Aidinian G., Weiswasser J.M., Arora S., Abularrage C.J., Singh N., and Sidawy A.N. Carotid plaque morphologic characteristics. Perspect Vasc Surg Endovasc Ther 18 (2006) 63-70
29. Eto H., Miyata M., Kume N., Minami M., Itabe H., Orihara K., et al. Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury. Biochem Biophys Res Commun 341 (2006) 591-598
30. Perler B.A. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg 20 (2007) 252-258